Alicia C Olivo insider trades: Neogenomics (NEO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alicia reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | NEO | ↓ Sell | 20,916 | $12.00 | $251K | Direct | Nov 28, 2025 (3d) |
| Oct 16, 2025 | NEO | ↓ Sell | 4,918 | $10.00 | $49K | Direct | Oct 20, 2025 (4d) |
| Nov 15, 2024 | NEO | ↓ Sell | 5,175 | $15.36 | $79K | Direct | Nov 19, 2024 (4d) |
| Aug 15, 2024 | NEO | ↓ Sell | 1,040 | $16.05 | $17K | Direct | Aug 19, 2024 (4d) |
| May 15, 2024 | NEO | ↓ Sell | 1,049 | $15.74 | $17K | Direct | May 17, 2024 (2d) |
| Feb 15, 2024 | NEO | ↓ Sell | 2,587 | $14.96 | $39K | Direct | Feb 20, 2024 (5d) |
| Nov 17, 2023 | NEO | ↓ Sell | 2,669 | $18.39 | $49K | Direct | Nov 20, 2023 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NEO insiders
Open-market trades in the last 12 months
About Alicia C Olivo's insider trades
Alicia C Olivo is EVP, GC & Business Development at Neogenomics (NEO). Since Nov 17, 2023, Alicia has reported no open-market purchases and 7 sales worth $501K on SEC Form 4. In the last 12 months: 1 sale ($251K).
Their filings also include shares withheld for taxes (18 filings), option exercises (7 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.